Covaxin phase II/III clinical trials for 2-18 age group to begin in 10-12 days: Govt
May 18, 2021
New Delhi [India], May 18 : Bharat Biotech is set to begin the phase II and III clinical trials for COVID-19 vaccine Covaxin in children in the age group of 2 to 18 years in the next 10-12 days, informed VK Paul, Member (Health), Niti Aayog on Tuesday.